- Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act.Piotr Ozieranski & Shai Mulinari - 2022 - Big Data and Society 9 (1).details
|
|
What is the impact of patient recruitment on offshoring of clinical trials? [REVIEW]Maryam Kermanimojarad - 2020 - Life Sciences, Society and Policy 16 (1):1-12.details
|
|
C. S. Peirce and Intersemiotic Translation.Joao Queiroz & Daniella Aguiar - 2015 - In Peter Pericles Trifonas (ed.), International Handbook of Semiotics. Dordrecht: Springer. pp. 201-215.details
|
|
The scientific dimensions of social knowledge and their distant echoes in 20th-century American philosophy of science.Philip Mirowski - 2004 - Studies in History and Philosophy of Science Part A 35 (2):283-326.details
|
|
Can patents prohibit research? On the social epistemology of patenting and licensing in science.Justin B. Biddle - 2014 - Studies in History and Philosophy of Science Part A 45:14-23.details
|
|
Managing the future: The Special Virus Leukemia Program and the acceleration of biomedical research.Robin Wolfe Scheffler - 2014 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 48 (PB):231-249.details
|
|
A new direction for science and values.Daniel J. Hicks - 2014 - Synthese 191 (14):3271-95.details
|
|
Institutional mistrust in the organization of pharmaceutical clinical trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.details
|
|
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light on.Sergio Sismondo - 2013 - Journal of Law, Medicine and Ethics 41 (3):635-643.details
|
|
In favour of a Millian proposal to reform biomedical research.Julian Reiss - 2010 - Synthese 177 (3):427 - 447.details
|
|
Political philosophy of science in logical empiricism: the left Vienna Circle.Thomas Uebel - 2005 - Studies in History and Philosophy of Science Part A 36 (4):754-773.details
|
|
On Commodification and the Governance of Academic Research.Merle Jacob - 2009 - Minerva 47 (4):391-405.details
|
|
The Pharmaceutical Commons: Sharing and Exclusion in Global Health Drug Development.Catherine M. Montgomery & Javier Lezaun - 2015 - Science, Technology, and Human Values 40 (1):3-29.details
|
|
Expert Judgment versus Market Accounting in an Industrial Research Lab.Eric Giannella - 2016 - Science, Technology, and Human Values 41 (3):402-437.details
|
|
Informing materials: drugs as tools for exploring cancer mechanisms and pathways.Etienne Vignola-Gagné, Peter Keating & Alberto Cambrosio - 2017 - History and Philosophy of the Life Sciences 39 (2):10.details
|
|
Capitalizing Disease.Amit Prasad - 2009 - Theory, Culture and Society 26 (5):1-29.details
|
|
Financial Conflicts of Interest and Criteria for Research Credibility.Kevin C. Elliott - 2014 - Erkenntnis 79 (5):917-937.details
|
|
Attitudes of Future Doctors of Bangladesh to Pharmaceutical Incentives and Medical Ethics.Tonmoy Biswas & Darryl Macer - 2017 - Eubios Journal of Asian and International Bioethics 27 (3):70-80.details
|
|
Hoedown at the OK Corral: more reflections on the ‘social’ in current philosophy of science.Philip Mirowski - 2005 - Studies in History and Philosophy of Science Part A 36 (4):790-800.details
|
|
How to produce ‘marketable and profitable results for the company’: from viral interference to Roferon A.Carsten Timmermann - 2019 - History and Philosophy of the Life Sciences 41 (3):30.details
|
|
Corporate Disguises in Medical Science: Dodging the Interest Repertoire.Sergio Sismondo - 2011 - Bulletin of Science, Technology and Society 31 (6):482-492.details
|
|
Interpellating Patients as Users: Patient Associations and the Project-Ness of Stem Cell Research.Henriette Langstrup - 2011 - Science, Technology, and Human Values 36 (4):573-594.details
|
|
Compliance revisited: pharmaceutical drug trials in the era of the contract research organization.Petra Jonvallen - 2009 - Nursing Inquiry 16 (4):347-354.details
|
|
The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals. [REVIEW]John Abraham - 2008 - Medicine, Health Care and Philosophy 11 (4):415-426.details
|
|
Social Studies of Science.Sergio Sismondo - unknowndetails
|
|